Clinical Trials on Programmed Cell Death Protein 1 Inhibitor in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Iyad Naeem Muhammad, PhD
- Foshan Sanshui District People's Hospital
- Arsha Vidya Tirtha
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Gunkang Pharmaceuticals, Inc
- Korea Otsuka International Asia Arab
- Sudimplant SAS - Groupe TBR
- United States Department of Defense (DOD)
- S-Biotek Holding ApS
- Rivierduinen, Centre for Personality disorders Jelgersma
- University of Applied Sciences Jena
- Oblikue Consulting
- Eurotrials Brasil Consultores Cientificos Ltda
- Paulo Sérgio Gomes Nogueira Borges
- Lilly PharmaceuticalCompany
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Plethora Solutions Ltd
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Julian Taylor Green
- View Full List
Medical Conditions
- Hidden Blood Loss
- Showing the Results of a Program of NHS in Cuiaba_ Brazil
- Spinocerebellar Ataxia 29
- HoFH
- SCLC
- Monogenic Lupus
- Traumatic Encephalopathy, Chronic
- Symptomatic Supraventricular Tachycardia
- Screening Compliance
- Raynaud Phenomena
- Glottic Web of Larynx
- Coccyx Injury
- Outcome After Hepatectomy
- Developmental Dislocation of Hip
- Keratoplasty
- Correction of the Moderate to Severe Nasolabial Folds
- HOMA-IR
- Bowel Preparation Before Colonoscopy
- Metastatic Platinum-Resistant Ovarian Carcinoma
- Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
- View Full List
Drug Interventions
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- F520
- Standard medical therapy
- S-Adenosyl-Methionine
- Pegfilgrastim
- Vosaroxin
- Bimatoprost 0.03% eye drops
- Pemetrexed
- Ebselen
- MMV390048 120mg
- Mineralocorticoid receptor antagonist
- Oxycodone
- Celecoxib
- Acalabrutinib in combination with VR
- Cyanoacrylate
- Furmonertinib 160 mg
- Sorafenib
- Rovalpituzumab tesirine
- Cytisine
- ABY-035 i.v.
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Austria
- Contract Research Organizations in Benin
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Georgia
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Qatar
- Contract Research Organizations in Romania
- Contract Research Organizations in South Africa
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uganda
- CRO list by country